🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsClinical Trials & ResearchAmycretin (Novo Nordisk) — amylin/GLP-1 co-agonist Phase 1 data Page 2

Amycretin (Novo Nordisk) — amylin/GLP-1 co-agonist Phase 1 data

TrialNerd_Beth Tue, Jun 2, 2026 at 3:36 AM 9 replies 247 viewsPage 2 of 2
Dr.PathRoch
Member
456
2,123
Jun 2024
Rochester, MN
Jun 2, 2026 at 4:43 AM#6

Adding the numbers, since they settle part of this. Keep the original post as written when you update it, and add the correction underneath. An edited-away mistake is invisible to the next person who makes it.

4 7MikeFit_NJ, InsuranceTom, WendyG_ATL and 1 other
Reply Quote Save Share Report
BrianDallas92
Member
312
1,456
Oct 2024
Dallas, TX
Jun 2, 2026 at 5:09 AM#7

Following on from NurseAsh_DET — and this may be the naive question:

How would you tell the difference between that and the alternative explanation?

5 8mona_PHX, andrew_nyc, Dr.EndoEP and 2 others
Reply Quote Save Share Report
Dr.ReproEndo
Senior Member
1,890
8,901
Jan 2024
Scottsdale, AZ
Jun 2, 2026 at 5:35 AM#8
Dr.PathRoch said:
Keep the original post as written when you update it, and add the correction underneath.

There is a second half to this that has not been said yet. The mechanism and the magnitude are separate questions. Agreeing that something happens says nothing about whether it happens enough to act on.

6 9Dr.EndoEP, GraceAZ_72, carl_compliance and 3 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
TrialNerd_Beth
Senior Member
2,345
11,234
Jan 2024
Bethesda, MD
Jun 2, 2026 at 6:01 AM#9

OP back with an update, since a thread like this is useless without one.

Closing this out. What actually changed my mind was the point about waiting for a trend instead of reading a single measurement, which is embarrassing in hindsight and worth saying anyway.

7 10DoseLogDan, SleepFixSam, PurityPaulOR and 4 others
Reply Quote Save Share Report
nick_SD_fit
Member
278
1,234
Sep 2024
San Diego, CA
Jun 2, 2026 at 8:06 AM#10
Dr.ReproEndo said:
The mechanism and the magnitude are separate questions.

Agreed, and the size of the effect matters as much as its existence. Something real and small gets treated here as though it were real and decisive.

Last edited: Jun 2, 2026 at 10:06 AM
45 20SurmountFan_IN, PeptideChemSF, A1cHero_PHX and 42 others
Reply Quote Save Share Report

Similar Threads

FLOW trial: semaglutide renal outcomes — NEJM publication review14 replies
SELECT trial: semaglutide 2.4mg cardiovascular outcomes — 4yr data9 replies
TRIUMPH program (retatrutide) — Phase 3 trial design and endpoints13 replies
Orforglipron ATTAIN trials — oral non-peptide GLP-1 agonist8 replies
CagriSema (amylin + semaglutide) — REDEFINE Phase 3 results20 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register